Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (21-30 of 785) with videos related to

Pageof 79
Sort By:
Circulation|June 12, 2019
More CREDENCE for SGLT2 InhibitionSubodh Verma, Deepak L Bhatt
Journal of the American College of Cardiology|December 4, 2003
Coxibs and the endotheliumSubodh Verma, Paul E Szmitko
Circulation|January 20, 2005
Cardiology patient pages. Red wine and your heartPaul E Szmitko, Subodh Verma
Clinical Science (London, England : 1979)|April 1, 2005
C-reactive protein and statins: IL-8 as a molecular link?Paul E Szmitko, Subodh Verma
The Canadian Journal of Cardiology|February 25, 2005
Painful legs, aching heart: Reducing cardiovascular risk in patients with peripheral arterial disease with angiotensin-converting enzyme inhibitionMilan K Gupta, Subodh Verma
Nature Clinical Practice. Cardiovascular Medicine|February 21, 2007
Skeletonized internal thoracic arteries for CABG surgery: a new gold standard?Subodh Verma, Christopher M Feindel
Circulation Research|May 26, 2007
C-reactive protein and reendothelialization: NO involvementPaul E Szmitko, Subodh Verma
The New England Journal of Medicine|May 12, 2006
Regression of aortic aneurysms through pharmacologic therapy?Subodh Verma, Thomas F Lindsay
Journal of the Cardiometabolic Syndrome|August 7, 2007
C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?Paul E Szmitko, Subodh Verma
The Canadian Journal of Cardiology|December 26, 2019
Does Interleukin-17A Blockade Have a Potential Clinical Role to Reduce Cardiovascular Risk in Psoriasis?Subodh Verma, Deepak L Bhatt
Pageof 79

Showing results (21-30 of 785) with videos related to

Sort By:
Pageof 79
Circulation|June 12, 2019
More CREDENCE for SGLT2 InhibitionSubodh Verma, Deepak L Bhatt
Journal of the American College of Cardiology|December 4, 2003
Coxibs and the endotheliumSubodh Verma, Paul E Szmitko
Circulation|January 20, 2005
Cardiology patient pages. Red wine and your heartPaul E Szmitko, Subodh Verma
Clinical Science (London, England : 1979)|April 1, 2005
C-reactive protein and statins: IL-8 as a molecular link?Paul E Szmitko, Subodh Verma
The Canadian Journal of Cardiology|February 25, 2005
Painful legs, aching heart: Reducing cardiovascular risk in patients with peripheral arterial disease with angiotensin-converting enzyme inhibitionMilan K Gupta, Subodh Verma
Nature Clinical Practice. Cardiovascular Medicine|February 21, 2007
Skeletonized internal thoracic arteries for CABG surgery: a new gold standard?Subodh Verma, Christopher M Feindel
Circulation Research|May 26, 2007
C-reactive protein and reendothelialization: NO involvementPaul E Szmitko, Subodh Verma
The New England Journal of Medicine|May 12, 2006
Regression of aortic aneurysms through pharmacologic therapy?Subodh Verma, Thomas F Lindsay
Journal of the Cardiometabolic Syndrome|August 7, 2007
C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?Paul E Szmitko, Subodh Verma
The Canadian Journal of Cardiology|December 26, 2019
Does Interleukin-17A Blockade Have a Potential Clinical Role to Reduce Cardiovascular Risk in Psoriasis?Subodh Verma, Deepak L Bhatt
Pageof 79